Back to List View Graph View

Yes-associated protein 1 (YAP1)

Yes-Associated Protein 1 (YAP1) is a transcriptional coactivator protein that serves as a principal effector of the Hippo signaling pathway.

Where the papers sit

12 papers from the last 6 months study Yes-associated protein 1 (YAP1) directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 1 observational · 8 preclinical · 3 unclassified

Themes 3 themes

  • Hippo-YAP Biology

    Hippo-YAP signaling is being examined across cancer, reproductive aging, and therapeutic delivery rather than one disease. YAP1 and WWTR1 silencing with chemically optimized siRNA-LNPs represents a direct intervention, while prognostic work tests protein and genetic markers in small-cell neuroendocrine tumors. HCC studies link pathway activation to metabolic disorders, and aging-associated chromatin repression connects it to ovarian germ-cell decline. Radiotherapy-induced chemokine decoys extend treatment concepts into glioblastoma, but no single clinical direction dominates.

    5 papers · 41.7%

  • YAP1-Driven Cancer Progression

    YAP1 is emerging as a convergence point for metabolic, inflammatory, and redox signals that sustain solid-tumor growth. ROS-MST1-YAP activation is being therapeutically reversed by ultrasound-responsive nanodroplets, while photodynamic and photothermal treatment disrupts YAP1/β-catenin in osteosarcoma. HRH1-YAP1 feedback in pancreatic cancer and obesity-linked GABA loss with metabolic rewiring in colorectal cancer add disease-specific drivers. The field is moving toward mechanism-matched combinations and YAP1-linked response prediction, but evidence remains largely preclinical.

    4 papers · 33.3%

  • Matrix-Driven YAP1 Remodeling

    Matrix mechanics and injury-associated metabolism are being linked to YAP1-driven tissue remodeling. Collagen-based conductive hydrogels use mechanoelectrical signaling to promote neuronal differentiation, whereas kidney injury work targets YAP1-mediated tubular-cell senescence to limit maladaptive repair and fibrosis. In diabetic retinopathy, lactate-induced MBD2 K186 lactylation drives YAP1-dependent myofibroblast-like Müller-cell remodeling. The shared direction is to modulate YAP1 according to tissue context—enhancing regenerative differentiation while restraining fibrotic conversion.

    3 papers · 25%

Papers

The 12 papers from the last 6 months that study Yes-associated protein 1 (YAP1) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Hippo-YAP Biology (5)
  1. Age-associated chromatin repression of Hippo-Yap signaling drives oogonial stem cell decline in chicken. Functional & integrative genomics · 7 Sept 2026 PMID 42704492
  2. Tumorigenesis of Hepatocellular Carcinoma Related to Metabolic Disorders With a Focus on the Hippo Pathway. Applied immunohistochemistry & molecular morphology : AIMM · 22 Jul 2026 PMID 42482663
  3. Optimized Chemical Modifications Enhance Lipid Nanoparticle-Mediated siRNA Silencing of YAP1 and WWTR1. Nucleic acid therapeutics · 22 Jul 2026 PMID 42482513
  4. Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392408
  5. Comparison of protein-based and genetic prognostic markers in a large cohort of primary pulmonary and extrapulmonary small cell neuroendocrine carcinoma. Lung cancer (Amsterdam, Netherlands) · 30 May 2026 PMID 42217423
YAP1-Driven Cancer Progression (4)
  1. Obesity-driven microbial GABA depletion promotes metabolic rewiring and colorectal cancer progression. Nature communications · 26 Jul 2026 PMID 42503520
  2. Ultrasound-responsive nanodroplets activate the Hippo pathway via ROS-MST1-YAP cascade for breast cancer therapy. Ultrasonics sonochemistry · 6 Jul 2026 PMID 42407381
  3. A HRH1-YAP1 feedback loop drives pancreatic cancer progression and predicts therapeutic response. Oncology letters · 1 Jul 2026 PMID 42383289
  4. A BODIPY-based nanotheranostic suppresses osteosarcoma via dual photodynamic/photothermal action by disruption of YAP1/β-catenin Axis. Journal of photochemistry and photobiology. B, Biology · 18 Jun 2026 PMID 42314525
Matrix-Driven YAP1 Remodeling (3)
  1. Lactate-induced MBD2 K186 lactylation promotes YAP1-dependent myofibroblast-like remodeling of Müller cells in diabetic retinopathy. Molecular biomedicine · 5 Oct 2026 PMID 42834249
  2. Targeting YAP1-Mediated Tubular Cell Senescence to Attenuate Maladaptive Repair and Fibrotic Transition After Acute Kidney Injury. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1 Jul 2026 PMID 42381472
  3. Bioinspired Anisotropic Collagen-Based Conductive Hydrogels Promote Neuronal Differentiation via Activation of Mechanoelectrical Signaling. ACS applied bio materials · 27 Jun 2026 PMID 42363939

By study type

Observational studies and case reports (1)
  1. Comparison of protein-based and genetic prognostic markers in a large cohort of primary pulmonary and extrapulmonary small cell neuroendocrine carcinoma. Lung cancer (Amsterdam, Netherlands) · 30 May 2026 PMID 42217423
Preclinical: animal, cell and lab studies (8)
  1. Lactate-induced MBD2 K186 lactylation promotes YAP1-dependent myofibroblast-like remodeling of Müller cells in diabetic retinopathy. Molecular biomedicine · 5 Oct 2026 PMID 42834249
  2. Age-associated chromatin repression of Hippo-Yap signaling drives oogonial stem cell decline in chicken. Functional & integrative genomics · 7 Sept 2026 PMID 42704492
  3. Obesity-driven microbial GABA depletion promotes metabolic rewiring and colorectal cancer progression. Nature communications · 26 Jul 2026 PMID 42503520
  4. Ultrasound-responsive nanodroplets activate the Hippo pathway via ROS-MST1-YAP cascade for breast cancer therapy. Ultrasonics sonochemistry · 6 Jul 2026 PMID 42407381
  5. Hijacking radiotherapy-induced chemokines with self-assembled molecular decoys for glioblastoma radio-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392408
  6. Targeting YAP1-Mediated Tubular Cell Senescence to Attenuate Maladaptive Repair and Fibrotic Transition After Acute Kidney Injury. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1 Jul 2026 PMID 42381472
  7. Bioinspired Anisotropic Collagen-Based Conductive Hydrogels Promote Neuronal Differentiation via Activation of Mechanoelectrical Signaling. ACS applied bio materials · 27 Jun 2026 PMID 42363939
  8. A BODIPY-based nanotheranostic suppresses osteosarcoma via dual photodynamic/photothermal action by disruption of YAP1/β-catenin Axis. Journal of photochemistry and photobiology. B, Biology · 18 Jun 2026 PMID 42314525
Unclassified: not yet indexed with MeSH (3)
  1. Tumorigenesis of Hepatocellular Carcinoma Related to Metabolic Disorders With a Focus on the Hippo Pathway. Applied immunohistochemistry & molecular morphology : AIMM · 22 Jul 2026 PMID 42482663
  2. Optimized Chemical Modifications Enhance Lipid Nanoparticle-Mediated siRNA Silencing of YAP1 and WWTR1. Nucleic acid therapeutics · 22 Jul 2026 PMID 42482513
  3. A HRH1-YAP1 feedback loop drives pancreatic cancer progression and predicts therapeutic response. Oncology letters · 1 Jul 2026 PMID 42383289